Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Sodium Zirconium Cyclosilicate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 392Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Astrazeneca India To Launch Sodium Zirconium Cyclosilicate Powder
    Astrazeneca India To Launch Sodium Zirconium Cyclosilicate Powder

    17 Oct 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/astrazeneca-pharma-india-to-launch-sodium-zirconium-cyclosilicate-powder-in-nov-2025-18015

    INDPHARMAPOST
    17 Oct 2025
    Share Share
    Alkem’s Generics Zirconium Receives Tentative Approval in US
    Alkem’s Generics Zirconium Receives Tentative Approval in US

    08 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217558

    FDA
    08 Oct 2025
    Share Share
    AstraZeneca approved to sell hyperkalaemia treatment in India
    AstraZeneca approved to sell hyperkalaemia treatment in India

    08 Mar 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-gets-nod-to-import-sell-hyperkalaemia-treatment-drug-in-india/articleshow/118760930.cms

    ECONOMICTIMES
    08 Mar 2025
    Share Share
    AstraZeneca calls off two late-stage potassium drug trials
    AstraZeneca calls off two late-stage potassium drug trials

    02 Dec 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-scrap-two-trials-drug-that-curbs-potassium-2023-12-01/

    REUTERS
    02 Dec 2023
    Share Share
    LOKELMA Granted FTD by FDA in Chronic Hemodialysis With Hyperkalemia
    LOKELMA Granted FTD by FDA in Chronic Hemodialysis With Hyperkalemia

    17 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211117006015/en

    BUSINESSWIRE
    17 Nov 2021
    Share Share
    Lokelma label update approved in China for patients with hyperkalaemia
    Lokelma label update approved in China for patients with hyperkalaemia

    24 Nov 2020

    // PRESS RELEASE

    https://www.astrazeneca.com/media-centre/press-releases/2020/lokelma-label-update-approved-in-china-for-patients-with-hyperka.html

    PRESS RELEASE
    24 Nov 2020
    Share Share